XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $483K invested in XTL Biopharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
U
1
UBS
Zurich,
Switzerland
|
$6K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$2K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $473K | 129,811 | – | – |
|
|
U
2
UBS
Zurich,
Switzerland
| $6K | 1,658 | +1,658 | New |
|
3
Ameriprise
Minneapolis,
Minnesota
| $2K | 441 | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2K | 500 | +149 | +42% |
|
5
Morgan Stanley
New York
| $0 | 3 | +3 | New |
|